Observational studyJournal of the American Heart Association2018

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.

Brandon K Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.